Drugs / BARDOXOLONE
BARDOXOLONE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00322140 | May 2006 → Jan 2008 | cancer, lymphoma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BARDOXOLONE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1093059 ↗ |
| Known as | Bardoxolona | ChEMBL registry synonym — accepted as the source's own label CHEMBL1093059 ↗ |
| Known as | CDDO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00322140 ↗ |
| Known as | RTA 401 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1093059 ↗ |
| Modality | Small molecule | — CHEMBL1093059 ↗ |